Royal London Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $41.5M | Sell |
|
|||||
|
2025
Q2 | $43.3M | Sell |
|
|||||
|
2025
Q1 | $58.1M | Sell |
|
|||||
|
2024
Q4 | $87.6M | Sell |
|
|||||
|
2024
Q3 | $80.1M | Buy |
|
|||||
|
2024
Q2 | $63.8M | Sell |
|
|||||
|
2024
Q1 | $92.4M | Buy |
|
|||||
|
2023
Q4 | $83.7M | Buy |
|
|||||
|
2023
Q3 | $92.3M | Buy |
|
|||||
|
2023
Q2 | $91.3M | Buy |
|
|||||
|
2023
Q1 | $83.1M | Buy |
|
|||||
|
2022
Q4 | $53.6M | Buy |
|
|||||
|
2022
Q3 | $52M | Sell |
|
|||||
|
2022
Q2 | $60.4M | Buy |
|
|||||
|
2022
Q1 | $57M | Buy |
|
|||||
|
2021
Q4 | $48.3M | Sell |
|
|||||
|
2021
Q3 | $47.1M | Sell |
|
|||||
|
2021
Q2 | $54.5M | Sell |
|
|||||
|
2021
Q1 | $53.9M | Buy |
|
|||||
|
2020
Q4 | $51.4M | Sell |
|
|||||
|
2020
Q3 | $52.1M | Sell |
|
|||||
|
2020
Q2 | $51.3M | Sell |
|
|||||
|
2020
Q1 | $50.5M | Sell |
|
|||||
|
2019
Q4 | $59.4M | Buy |
|
|||||
|
2019
Q3 | $32.7M | Sell |
|
|||||
|
2019
Q2 | $29.7M | Sell |
|
|||||
|
2019
Q1 | $31.8M | Sell |
|
|||||
|
2018
Q4 | $35.2M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $37.9M | Buy |
|
|||||
|
2016
Q2 | $41.4M | Sell |
|
|||||
|
2016
Q1 | $409K | Buy |
|
|||||
|
2015
Q4 | $41.8M | Buy |
|
|||||
|
2015
Q3 | $34.9M | Buy |
|
|||||
|
2014
Q4 | $311K | Buy |
|
|||||
|
2014
Q3 | $20.9M | Buy |
|
|||||
|
2014
Q2 | $19M | Sell |
|
|||||
|
2014
Q1 | $20.1M | Sell |
|
|||||
|
2013
Q4 | $22.3M | Buy |
|
|||||
|
2013
Q3 | $19.1M | Buy |
|
|||||
|
2013
Q2 | $17.7M | Buy |
|